This funding opportunity supports a cooperative multi-center program dedicated to developing, optimizing, and evaluating clinical transplant tolerance regimens. The goal is to achieve long-term graft survival without the need for lifelong immunosuppressive drugs by inducing and maintaining immune tolerance to allogeneic transplants using translationally relevant models.
Eligible applicants include a wide range of government entities, educational institutions, tribal governments and organizations, nonprofits, for-profit organizations, small businesses, and other specified groups. Specific eligibility details are provided in the announcement.
